Detail akcie West Pharm Svc online

Business Summary: West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Financial Summary: BRIEF: For the three months ended 31 March 2025, West Pharmaceutical Services Inc revenues increased less than 1% to $698M. Net income decreased 22% to $89.8M. Revenues reflect market conditions. Net income was partially offset by Selling, general and administrative expe increase of 1% to $88M (expense), Equity Earnings – Net of Income Tax decrease of 21% to $3.4M (earnings). Dividend per share increased from $0.20 to $0.21.